NDC 0024-5918
Dupixent 200 mg per 1.14 mL injection, solution
On the label: Sanofi-Aventis U.S. LLC.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Regeneron Ireland Designated Activity Company | Limerick, Ireland | Makes the active ingredient and tests it | Problems found, fixed voluntarilyJun 13, 2025 · 2 inspections |
| Regeneron Pharmaceuticals, Inc. | Rensselaer, NY, United States | Makes the active ingredient and tests it | Problems found, fixed voluntarilyMar 22, 2024 · 10 inspections |
| Sanofi Winthrop Industrie | Le Trait, France | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyApr 25, 2023 · 6 inspections |
| Sanofi-Aventis Deutschland GmbH | Frankfurt am Main, Germany | Tests it | Problems found, fixed voluntarilyMar 25, 2022 · 10 inspections, 1 with FDA action |
Product details
- Generic drug
- Dupilumab: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 200 mg per 1.14 mL
- Approval
- BLA BLA761055
- On the market since
- Oct 19, 2018
- Package NDCs
0024-5918-000024-5918-010024-5918-020024-5918-20- Official label
- DailyMed (National Library of Medicine), updated Apr 22, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?